Файл: 2021Возрастная категория Взрослые,ДетиПересмотр не позднее 2023.pdf

17. Newsome J. et al. Postpartum Hemorrhage // Tech. Vasc. Interv. Radiol. 2017. Vol. 20, № 4. P.
266–273.
18. Silver R.M., Major H. Maternal coagulation disorders and postpartum hemorrhage // Clinical
Obstetrics and Gynecology. 2010.
19. Main E.K. et al. National Partnership for Maternal Safety // Obstet. Gynecol. 2015. Vol. 126, № 1. P. 155–162.
20. Durmaz A., Komurcu N. Relationship between Maternal Characteristics and Postpartum
Hemorrhage: A Meta-Analysis Study // J. Nurs. Res. 2018.
21. Ende H.B. et al. Risk Factors for Atonic Postpartum Hemorrhage // Obstet. Gynecol. 2021. Vol.
137, № 2. P. 305–323.
22. Jung J. et al. Effects of hemoglobin levels during pregnancy on adverse maternal and infant outcomes: a systematic review and meta
‐analysis // Ann. N. Y. Acad. Sci. 2019. Vol. 1450, № 1. P.
nyas.14112.
23. Buca D. et al. Influence of prenatal diagnosis of abnormally invasive placenta on maternal outcome: systematic review and meta-analysis. // Ultrasound Obstet. Gynecol. 2018. Vol. 52, № 3. P.
304–309.
24. Andrikopoulou M., D’Alton M.E. Postpartum hemorrhage: early identification challenges //
Semin. Perinatol. 2019. Vol. 43, № 1. P. 11–17.
25. Green L. et al. The epidemiology and outcomes of women with postpartum haemorrhage requiring massive transfusion with eight or more units of red cells: A national cross
‐sectional study //
BJOG An Int. J. Obstet. Gynaecol. 2016.
26. Larsson C. et al. Estimation of blood loss after cesarean section and vaginal delivery has low validity with a tendency to exaggeration // Acta Obstet. Gynecol. Scand. 2006.
27. van der Bom J.G. Viscoelastometric testing, fibrinogen and transfusion during post-partum haemorrhage // Br. J. Anaesth. 2017. Vol. 119, № 3. P. 352–353.
28. Collis R., Guasch E. Managing major obstetric haemorrhage: Pharmacotherapy and transfusion
// Best Practice and Research: Clinical Anaesthesiology. 2017.
29. Sentilhes L. et al. Postpartum hemorrhage: Guidelines for clinical practice from the French
College of Gynaecologists and Obstetricians (CNGOF): In collaboration with the French Society of
Anesthesiology and Intensive Care (SFAR) // Eur. J. Obstet. Gynecol. Reprod. Biol. 2016.
30. Kozek-Langenecker S.A. et al. Management of severe perioperative bleeding: Guidelines from the European Society of Anaesthesiology // European Journal of Anaesthesiology. 2017.

31. Solomon C., Collis R.E., Collins P.W. Haemostatic monitoring during postpartum haemorrhage and implications for management // Br. J. Anaesth. 2012.
32. Allard S., Green L., Hunt B.J. How we manage the haematological aspects of major obstetric haemorrhage // British Journal of Haematology. 2014.
33. Bell S.F. et al. The use of fibrinogen concentrate to correct hypofibrinogenaemia rapidly during obstetric haemorrhage // Int. J. Obstet. Anesth. 2010.
34. Sokologorsky S. V. A SIMPLE RAPID DIAGNOSING METHOD FOR HEMOSTASIS //
Wounds wound Infect. prof. B.M. Kostyuchenok J. 2015. Vol. 2, № 1. P. 49.
35. McNamara H. et al. Four years’ experience of a ROTEM®-guided algorithm for treatment of coagulopathy in obstetric haemorrhage // Anaesthesia. 2019.
36. Diaz V., Abalos E., Carroli G. Methods for blood loss estimation after vaginal birth // Cochrane
Database of Systematic Reviews. 2018.
37. Amgalan A. et al. Systematic review of viscoelastic testing (TEG/ROTEM) in obstetrics and recommendations from the women’s SSC of the ISTH // Journal of Thrombosis and Haemostasis.
2020.
38. Fahrendorff M., Oliveri R.S., Johansson P.I. The use of viscoelastic haemostatic assays in goal- directing treatment with allogeneic blood products - A systematic review and meta-analysis //
Scandinavian Journal of Trauma, Resuscitation and Emergency Medicine. 2017.
39. Babarinsa I.A., Hayman R.G., Draycott T.J. Secondary post-partum haemorrhage: Challenges in evidence-based causes and management // European Journal of Obstetrics and Gynecology and
Reproductive Biology. 2011.
40. Neill A., Thornton S. Secondary postpartum haemorrhage // J. Obstet. Gynaecol. (Lahore).
2002. Vol. 22, № 2. P. 119–122.
41. Dalton E., Castillo E. Post partum infections: A review for the non-OBGYN // Obstet. Med.
2014. Vol. 7, № 3. P. 98–102.
42. National Blood Authority. Patient Blood Management Guidelines: Module 5 - Obstetrics and
Maternity // Patient Blood Management Guidelines. 2015.
43. Schlembach D. et al. Peripartum haemorrhage, diagnosis and therapy. Guideline of the DGGG,
OEGGG and SGGG (S2k level, AWMF registry No. 015/063, March 2016) // Geburtshilfe und
Frauenheilkunde. 2018.
44. Pather S. et al. Postpartum curettage: An audit of 200 cases // Aust. New Zeal. J. Obstet.
Gynaecol. 2005.

45. De Vries J.I.P., Van Der Linden R.M., Van Der Linden H.C. Predictive value of sonographic examination to visualize retained placenta directly after birth at 16 to 28 weeks // J. Ultrasound Med.
2000.
46. Edwards A., Ellwood D.A. Ultrasonographic evaluation of the postpartum uterus // Ultrasound
Obstet. Gynecol. 2000. Vol. 16, № 7. P. 640–643.
47. Sadan O. et al. Role of Sonography in the Diagnosis of Retained Products of Conception // J.
Ultrasound Med. 2004.
48. Girault A. et al. Undiagnosed abnormal postpartum blood loss: Incidence and risk factors //
PLoS One / ed. Puebla I. 2018. Vol. 13, № 1. P. e0190845.
49. Lousquy R. et al. Routine use of abdominopelvic ultrasonography in severe postpartum hemorrhage: retrospective evaluation in 125 patients // Am. J. Obstet. Gynecol. 2011. Vol. 204, № 3. P.
232.e1-232.e6.
50. Lee N.K. et al. Identification of bleeding sites in patients with postpartum hemorrhage: MDCT
compared with angiography // Am. J. Roentgenol. 2010.
51. Brooks M. et al. Use of a Visual Aid in addition to a Collector Bag to Evaluate Postpartum
Blood loss: A Prospective Simulation Study // Sci. Rep. 2017. Vol. 7, № 1. P. 46333.
52. Patel A. et al. Drape estimation vs. visual assessment for estimating postpartum hemorrhage //
Int. J. Gynecol. Obstet. 2006.
53. Al Kadri H.M.F., Al Anazi B.K., Tamim H.M. Visual estimation versus gravimetric measurement of postpartum blood loss: a prospective cohort study // Arch. Gynecol. Obstet. 2011. Vol.
283, № 6. P. 1207–1213.
54. Zuckerwise L.C. et al. Use of a Novel Visual Aid to Improve Estimation of Obstetric Blood
Loss // Obstet. Gynecol. 2014. Vol. 123, № 5. P. 982–986.
55. Le Bas A. et al. Use of the “obstetric shock index” as an adjunct in identifying significant blood loss in patients with massive postpartum hemorrhage // Int. J. Gynecol. Obstet. 2014. Vol. 124, № 3. P.
253–255.
56. Girault A. et al. Undiagnosed abnormal postpartum blood loss: Incidence and risk factors //
PLoS One. 2018.
57. Lilley G. et al. Measurement of blood loss during postpartum haemorrhage // Int. J. Obstet.
Anesth. 2015.
58. Gwinnutt C.L., Driscoll P. Advanced trauma life support. ATLS® Student Manual 9th Edition.
Chicago, 2012. P. 420.

59. Rath W.H. Postpartum hemorrhage - Update on problems of definitions and diagnosis // Acta
Obstet. Gynecol. Scand. 2011.
60. Nathan H.L. et al. Determination of normal ranges of shock index and other haemodynamic variables in the immediate postpartum period: A cohort study // PLoS One. 2016.
61. Borovac-Pinheiro A. et al. Shock index and heart rate standard reference values in the immediate postpartum period: A cohort study // PLoS One. 2019.
62. Ushida T. et al. Shock Index and Postpartum Hemorrhage in Vaginal Deliveries: A Multicenter
Retrospective Study // Shock. 2021.
63. Green M. et al. Developing a Systematic Approach to Obstetric Emergencies // JOGNN - J.
Obstet. Gynecol. Neonatal Nurs. 2015.
64. Bajaj K. et al. Validating Obstetric Emergency Checklists using Simulation: A Randomized
Controlled Trial // Am. J. Perinatol. 2016. Vol. 33, № 12. P. 1182–1190.
65. Guise J.M., Mladenovic J. In situ simulation: Identification of systems issues // Seminars in
Perinatology. 2013.
66. Guise J.M. et al. Mobile in situ obstetric emergency simulation and teamwork training to improve maternal-fetal safety in hospitals // Jt. Comm. J. Qual. Patient Saf. 2010.
67. Obstetric Care Consensus No. 5: Severe Maternal Morbidity: Screening and Review //
Obstetrics and Gynecology. 2016.
68. Committee opinion no. 590: Preparing for clinical emergencies in obstetrics and gynecology //
Obstetrics and Gynecology. 2014.
69. Clark S.L. et al. Proposed diagnostic criteria for the case definition of amniotic fluid embolism in research studies // Am. J. Obstet. Gynecol. 2016.
70. Takeda S. et al. Japanese Clinical Practice Guide for Critical Obstetrical Hemorrhage (2017
revision) // J. Obstet. Gynaecol. Res. 2017.
71. RCOG. Prevention and Management of Postpartum Haemorrhage: Green-top Guideline No. 52.
// BJOG. 2017. Vol. 124, № 5. P. e106–e149.
72. WHO. WHO recommendations for the prevention and treatment of postpartum haemorrhage //
World Health Organization. 2018.
73. Parry Smith W.R. et al. Uterotonic agents for first-line treatment of postpartum haemorrhage: a network meta-analysis // Cochrane Database Syst. Rev. 2020.
74. Meckstroth K.R. et al. Misoprostol administered by epithelial routes: Drug absorption and uterine response // Obstet. Gynecol. 2006.

75. Georgiou C. Balloon tamponade in the management of postpartum haemorrhage: A review //
BJOG: An International Journal of Obstetrics and Gynaecology. 2009.
76. Adamson L. Scottish Confidential Audit of Severe Maternal Morbidity 10th Annual Report.
2014.
77. Tindell K. et al. Uterine balloon tamponade for the treatment of postpartum haemorrhage in resource-poor settings: a systematic review // BJOG An Int. J. Obstet. Gynaecol. 2013. Vol. 120, № 1.
P. 5–14.
78. Finlayson K. et al. Healthcare providers experiences of using uterine balloon tamponade (UBT)
devices for the treatment of post-partum haemorrhage: A meta-synthesis of qualitative studies // PLoS
One. 2021.
79. Anger H.A. et al. Postpartum infection, pain and experiences with care among women treated for postpartum hemorrhage in three African countries: A cohort study of women managed with and without condom-catheter uterine balloon tamponade // PLoS One. 2021.
80. Soued M. et al. Efficacy of Intra-Uterine Tamponade Balloon in Post-Partum Hemorrhage after
Cesarean Delivery: An Impact Study // J. Clin. Med. 2020.
81. Schorn M.N., Phillippi J.C. Volume Replacement Following Severe Postpartum Hemorrhage //
J. Midwifery Womens. Health. 2014. Vol. 59, № 3. P. 336–343.
82. Casey J.D., Brown R.M., Semler M.W. Resuscitation fluids // Current opinion in critical care.
2018.
83. Pacagnella R.C., Borovac-Pinheiro A. Assessing and managing hypovolemic shock in puerperal women // Best Practice and Research: Clinical Obstetrics and Gynaecology. 2019.
84. Malbrain M.L.N.G. et al. Intravenous fluid therapy in the perioperative and critical care setting:
Executive summary of the International Fluid Academy (IFA) // Annals of Intensive Care. 2020.
85. Collis R.E., Collins P.W. Haemostatic management of obstetric haemorrhage // Anaesthesia.
2015.
86. Mignon A., Dreyfus M., Ozier Y. Prise en charge initiale par l’anesthésiste en cas d’hémorragie du post-partum // Journal de Gynecologie Obstetrique et Biologie de la Reproduction. 2004.
87. Mavrides E., Allard S., Chandraharan E., Collins P., Green L., Hunt B. R.S., , Thomson A. on behalf of the R.C. of O. and G. Prevention and Management of Postpartum Haemorrhage // BJOG An
Int. J. Obstet. Gynaecol. 2017. Vol. 124, № 5. P. e106–e149.
88. Muñoz M. et al. Patient blood management in obstetrics: Prevention and treatment of postpartum haemorrhage. A NATA consensus statement: A multidisciplinary consensus statement //
Blood Transfus. 2019.

89. Gillissen A. et al. Association between fluid management and dilutional coagulopathy in severe postpartum haemorrhage: A nationwide retrospective cohort study // BMC Pregnancy Childbirth.
2018.
90. Keane M. Triad of death: The importance of temperature monitoring in trauma patients //
Emergency Nurse. 2016.
91. Harvey C.J. Evidence-based strategies for maternal stabilization and rescue in obstetric hemorrhage // AACN Adv. Crit. Care. 2018.
92. Kander T., Schött U. Effect of hypothermia on haemostasis and bleeding risk: a narrative review
// Journal of International Medical Research. 2019.
93. Likis F.E. et al. Management of Postpartum Hemorrhage Comparative Effectiveness Review
Management of Postpartum Hemorrhage. 2015. № 151.
94. Oyelese Y. et al. Postpartum Hemorrhage // Obstet. Gynecol. Clin. North Am. 2007. Vol. 34, № 3. P. 421–441.
95. Norfolk D. Handbook of Transfusion Medicine, United Kingdom Blood Services, 5th edition //
Handbook of Transfusion Medicine. 2015.
96. Llau J.V. et al. Multidisciplinary consensus document on the management of massive haemorrhage (HEMOMAS document) // Med. Intensiva (English Ed. 2015.
97. RCOG. Blood Transfusion in Obstetrics Royal College of Obstetricians and Gynaecologists
Green-top Guideline No. 47. 2015.
98. Holst L.B. et al. Restrictive versus liberal transfusion strategy for red blood cell transfusion:
Systematic review of randomised trials with meta-analysis and trial sequential analysis // BMJ
(Online). 2015.
99. Приказ Министерства здравоохранения РФ от 28 октября 2020 г. N 1170н "Об утверждении порядка оказания медицинской помощи населению по профилю
“трансфузиология.”
100. Jansen A. J. G. et al. Postpartum hemorrhage and transfusion of blood and blood components //
Obstet. Gynecol. Surv. – 2005. – Т. 60. – №. 10. – С. 663-671.
101. Kozek-Langenecker S.A. Fluids and coagulation // Current Opinion in Critical Care. 2015.
102. Sommer N. et al. Massive transfusion protocols in nontrauma patients: A systematic review and meta-analysis // Journal of Trauma and Acute Care Surgery. 2019.
103. Gutierrez M.C. et al. Postpartum hemorrhage treated with a massive transfusion protocol at a tertiary obstetric center: A retrospective study // Int. J. Obstet. Anesth. 2012.

104. Bhangu A. et al. Meta-analysis of plasma to red blood cell ratios and mortality in massive blood transfusions for trauma // Injury. 2013.
105. Butwick A.J., Goodnough L.T. Transfusion and coagulation management in major obstetric hemorrhage // Curr. Opin. Anaesthesiol. 2015. Vol. 28, № 3. P. 275–284.
106. Thomas D. et al. Blood transfusion and the anaesthetist: Management of massive haemorrhage
// Anaesthesia. 2010.
107. Shields L.E. et al. Comprehensive maternal hemorrhage protocols reduce the use of blood products and improve patient safety // American Journal of Obstetrics and Gynecology. 2015.
108. Shields L.E. et al. Comprehensive maternal hemorrhage protocols improve patient safety and reduce utilization of blood products // Am. J. Obstet. Gynecol. 2011.
109. Pasquier P. et al. An observational study of the fresh frozen plasma: Red blood cell ratio in postpartum hemorrhage // Anesth. Analg. 2013.
110. Wikkelsø A. et al. Thromboelastography (TEG) or thromboelastometry (ROTEM) to monitor haemostatic treatment versus usual care in adults or children with bleeding // Cochrane Database of
Systematic Reviews. 2016.
111. Snegovskikh D. et al. Point-of-care viscoelastic testing improves the outcome of pregnancies complicated by severe postpartum hemorrhage // J. Clin. Anesth. 2018.
112. Health Q. Post Partum Haemorrage Guidelines - Queensland 2018. 2018.
113. Burtelow M. et al. How we treat: Management of life-threatening primary postpartum hemorrhage with a standardized massive transfusion protocol // Transfusion. 2007.
114. Collins P., Abdul-Kadir R., Thachil J. Management of coagulopathy associated with postpartum hemorrhage: guidance from the SSC of the ISTH // J. Thromb. Haemost. 2016. Vol. 14, № 1. P. 205–
210.
115. Tevet A. et al. Peripartum use of cell salvage: A university practice audit and literature review //
Archives of Gynecology and Obstetrics. 2012.
116. National Clinical Guideline Center. Intravenous fluid therapy : Intravenous fluid therapy in adults in hospital // NICE Guidel. 2013.
117. ДОБРОХОТОВА Ю.Э. et al. Послеродовые кровотечения. Обоснование оптимальной гемостатической фармакотерапии. // Российский вестник акушера-гинеколога/. P. 99–102.
118. De Lloyd L. et al. Standard haemostatic tests following major obstetric haemorrhage // Int. J.
Obstet. Anesth. 2011.

119. Charbit B. et al. The decrease of fibrinogen is an early predictor of the severity of postpartum hemorrhage // J. Thromb. Haemost. 2007.
120. Collins P.W. et al. Fibrin-based clot formation as an early and rapid biomarker for progression of postpartum hemorrhage: a prospective study. // Blood. 2014.
121. Li G. et al. Incidence and transfusion risk factors for transfusion-associated circulatory overload among medical intensive care unit patients // Transfusion. 2011.
122. Teofili L. et al. Acute lung injury complicating blood transfusion in post-partum hemorrhage:
Incidence and risk factors // Mediterr. J. Hematol. Infect. Dis. 2014.
123. Stainsby D. et al. Guidelines on the management of massive blood loss // British Journal of
Haematology. 2006.
124. Chowdhury P. et al. Efficacy of standard dose and 30 ml/kg fresh frozen plasma in correcting laboratory parameters of haemostasis in critically ill patients // British Journal of Haematology. 2004.
125. Tikkanen M. Placental abruption: Epidemiology, risk factors and consequences // Acta
Obstetricia et Gynecologica Scandinavica. 2011.
126. Levi M. Pathogenesis and management of peripartum coagulopathic calamities (disseminated intravascular coagulation and amniotic fluid embolism) // Thromb. Res. 2013.
127. Ahmed S. et al. The efficacy of fibrinogen concentrate compared with cryoprecipitate in major obstetric haemorrhage - an observational study // Transfus. Med. 2012.
128. Cortet M. et al. Association between fibrinogen level and severity of postpartum haemorrhage:
Secondary analysis of a prospective trial // Br. J. Anaesth. 2012.
129. Collins P.W. et al. Theoretical modelling of fibrinogen supplementation with therapeutic plasma, cryoprecipitate, or fibrinogen concentrate // Br. J. Anaesth. 2014.
130. Gollop N.D. et al. National audit of the use of fibrinogen concentrate to correct hypofibrinogenaemia // Transfus. Med. 2012.
131. Роненсон А.М., Шифман Е.М., Куликов А.В., Распопин Ю.С. Референсные показатели ротационной тромбоэластометрии у беременных и рожениц: систематический обзор и метаанализ. // Анестезиология и реаниматология. 2021.
132. Hunt B.J. et al. A practical guideline for the haematological management of major haemorrhage
// Br. J. Haematol. 2015.
133. Rasmussen K.C. et al. Impact of albumin on coagulation competence and hemorrhage during major surgery: A randomized controlled trial // Med. (United States). 2016.
134. Jeremy W. Cannon M.D. Hemorragic shock // Th e new Engl. J. o f Med. 2018.

135. Lyndon A. et al. Improving Health Care Response to Obstetric Hemorrhage Version 2.0 // Calif.
Matern. Qual. Care Collab. 2015.
136. Куликов А.В., Овезов А.М., Пырегов А.В., Роненсон А.М., Шифман Е.М., Шмаков Р.Г.
Коррекция артериальной гипотонии при нейроаксиальной анестезии во время операции кесарево сечение. Клинические рекомендации (протокол лечения). 2018.
137. Роненсон A. М., Шифман Е. М., Куликов А.В. Тактика инфузионной терапии при послеродовом кровотечении: какие ориентиры выбрать? // Анестезиология и реаниматология.
2018. № 5. P. 15.
138. AAGBI. Blood Transfusion and the Anaesthetist, intra-operative Cell Salvage. // Assoc.
Anaesth. Gt. Britain Irel. 2009.
139. Hahn R.G. Adverse effects of crystalloid and colloid fluids // Anaesthesiology Intensive
Therapy. 2017.
140. Henriquez D.D.C.A. et al. Fluid resuscitation during persistent postpartum haemorrhage and maternal outcome: A nationwide cohort study // Eur. J. Obstet. Gynecol. Reprod. Biol. 2019. Vol. 235.
P. 49–56.
141. Roubinian N.H., Triulzi D.J. Transfusion-Associated Circulatory Overload and Transfusion-
Related Acute Lung Injury // Hematol. Oncol. Clin. North Am. 2019. Vol. 33, № 5. P. 767–779.
142. Bosboom J.J. et al. Transfusion-Associated Circulatory Overload: A Clinical Perspective //
Transfus. Med. Rev. 2019. Vol. 33, № 2. P. 69–77.
143. Shakur H. et al. Effect of early tranexamic acid administration on mortality, hysterectomy, and other morbidities in women with post-partum haemorrhage (WOMAN): an international, randomised,
double-blind, placebo-controlled trial // Lancet. 2017.
144. Stortroen N.E., Tubog T.D., Shaffer S.K. Prophylactic tranexamic acid in high-risk patients undergoing cesarean delivery: A systematic review and meta-analysis of randomized controlled trials //
AANA Journal. 2020.
145. Fahrenholtz C.G., Bonanno L.S., Martin J.B. Tranexamic acid as adjuvant treatment for postpartum hemorrhage: A systematic review protocol // JBI Database of Systematic Reviews and
Implementation Reports. 2019.
146. Ducloy-Bouthors A.-S. et al. High-dose tranexamic acid reduces blood loss in postpartum haemorrhage // Crit. Care. 2011. Vol. 15, № 2. P. R117.
147. Ahmadzia H.K. et al. Tranexamic Acid for Prevention and Treatment of Postpartum
Hemorrhage: An Update on Management and Clinical Outcomes // Obstet. Gynecol. Surv. 2018.
148. Hutton B. et al. Risks of harms using antifibrinolytics in cardiac surgery: Systematic review and network meta-analysis of randomised and observational studies // BMJ. 2012.

149. Meybohm P. et al. Aprotinin May Increase Mortality in Low and Intermediate Risk but Not in
High Risk Cardiac Surgical Patients Compared to Tranexamic Acid and ε-Aminocaproic Acid - A
Meta-Analysis of Randomised and Observational Trials of over 30.000 Patients // PLoS One. 2013.
150. Lavigne-Lissalde G. et al. Recombinant human FVIIa for reducing the need for invasive second-line therapies in severe refractory postpartum hemorrhage: A multicenter, randomized, open controlled trial // J. Thromb. Haemost. 2015.
151. National Institute for Health and Care Excellence (UK). Blood Transfusion NICE Guideline
[NG24]. 2015.
152. Shaylor R. et al. National and International Guidelines for Patient Blood Management in
Obstetrics // Anesth. Analg. 2017. Vol. 124, № 1. P. 216–232.
153. Vaught A.J. Critical Care for the Obstetrician and Gynecologist // Obstet. Gynecol. Clin. North
Am. 2016. Vol. 43, № 4. P. 611–622.
154. Practice Guidelines for Perioperative Blood Management: an updated report by the American
Society of Anesthesiologists Task Force on Perioperative Blood Management // Anesthesiology. 2015.
Vol. 122, № 2. P. 241–275.
155. Alfirevic Z. et al. Use of recombinant activated factor vii in primary postpartum hemorrhage:
The northern European registry 2000-2004 // Obstet. Gynecol. 2007.
156. Huber A.W. et al. Recombinant human factor VIIa prevents hysterectomy in severe postpartum hemorrhage: Single center study // Journal of Perinatal Medicine. 2012.
157. Phillips L.E. et al. Recombinant activated factor VII in obstetric hemorrhage: Experiences from the Australian and New Zealand haemostasis registry // Anesth. Analg. 2009.
158. Franchini M. et al. Potential role of recombinant activated factor VII for the treatment of severe bleeding associated with disseminated intravascular coagulation: A systematic review // Blood
Coagulation and Fibrinolysis. 2007.
159. Brenner B., Wiis J. Experience with recombinant-activated factor VII in 30 patients with congenital factor VII deficiency // Hematology. 2007.
160. Flessa H.C. et al. Placental transport of heparin // Am. J. Obstet. Gynecol. 1965.
161. Clark N.P. et al. A descriptive evaluation of unfractionated heparin use during pregnancy // J.
Thromb. Thrombolysis. 2009. Vol. 27, № 3. P. 267–273.
162. Ginsberg J.S. Heparin Therapy During Pregnancy // Arch. Intern. Med. 1989. Vol. 149, № 10. P.
2233.
163. Karino T., Motomiya M. Flow through a venous valve and its implication for thrombus formation // Thromb. Res. 1984. Vol. 36, № 3. P. 245–257.